Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

305 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Survivin-specific T-cell reactivity correlates with tumor response and patient survival: a phase-II peptide vaccination trial in metastatic melanoma.
Becker JC, Andersen MH, Hofmeister-Müller V, Wobser M, Frey L, Sandig C, Walter S, Singh-Jasuja H, Kämpgen E, Opitz A, Zapatka M, Bröcker EB, Thor Straten P, Schrama D, Ugurel S. Becker JC, et al. Among authors: ugurel s. Cancer Immunol Immunother. 2012 Nov;61(11):2091-103. doi: 10.1007/s00262-012-1266-9. Epub 2012 May 8. Cancer Immunol Immunother. 2012. PMID: 22565484 Free PMC article. Clinical Trial.
Immunogenicity of constitutively active V599EBRaf.
Andersen MH, Fensterle J, Ugurel S, Reker S, Houben R, Guldberg P, Berger TG, Schadendorf D, Trefzer U, Bröcker EB, Straten Pt, Rapp UR, Becker JC. Andersen MH, et al. Among authors: ugurel s. Cancer Res. 2004 Aug 1;64(15):5456-60. doi: 10.1158/0008-5472.CAN-04-0937. Cancer Res. 2004. PMID: 15289355
Lack of clinical efficacy of imatinib in metastatic melanoma.
Ugurel S, Hildenbrand R, Zimpfer A, La Rosée P, Paschka P, Sucker A, Keikavoussi P, Becker JC, Rittgen W, Hochhaus A, Schadendorf D. Ugurel S, et al. Br J Cancer. 2005 Apr 25;92(8):1398-405. doi: 10.1038/sj.bjc.6602529. Br J Cancer. 2005. PMID: 15846297 Free PMC article. Clinical Trial.
Dacarbazine (DTIC) versus vaccination with autologous peptide-pulsed dendritic cells (DC) in first-line treatment of patients with metastatic melanoma: a randomized phase III trial of the DC study group of the DeCOG.
Schadendorf D, Ugurel S, Schuler-Thurner B, Nestle FO, Enk A, Bröcker EB, Grabbe S, Rittgen W, Edler L, Sucker A, Zimpfer-Rechner C, Berger T, Kamarashev J, Burg G, Jonuleit H, Tüttenberg A, Becker JC, Keikavoussi P, Kämpgen E, Schuler G; DC study group of the DeCOG. Schadendorf D, et al. Among authors: ugurel s. Ann Oncol. 2006 Apr;17(4):563-70. doi: 10.1093/annonc/mdj138. Epub 2006 Jan 17. Ann Oncol. 2006. PMID: 16418308 Free article. Clinical Trial.
Molecular mechanisms in melanoma.
Ugurel S, Houben R, Becker JC. Ugurel S, et al. N Engl J Med. 2006 Sep 28;355(13):1395-6; author reply 1396. N Engl J Med. 2006. PMID: 17014045 No abstract available.
305 results